Normalization of CSF pTau measurement by Aβ 40 improves its performance as a biomarker of Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

Normalization of CSF pTau measurement by Aβ 40 improves its performance as a biomarker of Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

Normalization of CSF pTau measurement by Aβ40 improves its performance as a biomarker of Alzheimer’s disease

Alzheimer’s disease (AD)-related tauopathy can be measured with CSF phosphorylated tau (pTau) and tau PET. We aim to investigate the associations between these measurements and their relative ability to predic...

Authors:Tengfei Guo, Deniz Korman, Renaud La Joie, Leslie M. Shaw, John Q. Trojanowski, William J. Jagust and Susan M. Landau

Citation:Alzheimer's Research & Therapy 2020 12:97

Content type:Research

Published on: 15 August 2020

• ViewFull Text
 
• ViewPDF